Rubicon Research Limited (BOM:544578)
1,565.05
+50.10 (3.31%)
At close: Oct 28, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 258.89 billion as of October 28, 2026. Its market cap has increased by 166.41% in one year.
Market Cap
258.89B
Enterprise Value
258.67B
Revenue
19.36B
Global Rank
n/a
Country Rank
n/a
PE Ratio
89.10
ChartMarket Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 258.89B, an increase of 150.15%. That is a compound annual growth rate of 142.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 258.89B | 130.84% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 258.89B |
| Pfizer | 170.84B |
| Marksans Pharma | 138.31B |
| CORONA Remedies | 134.59B |
| Sanofi Consumer Healthcare India | 76.53B |
| Senores Pharmaceuticals | 60.99B |
| SMS Pharmaceuticals | 44.53B |
| Sai Parenteral's | 21.38B |